Articles

When it comes to interventional cardiology, increasing diagnostic confidence and reducing exam time are paramount to improving overall patient care.

Tony Pinson, RTRCV, has worked at Carroll Hospital Center in Westminster, Md., for nearly 20 years. During that time, the cardiac catheterization laboratory supervisor has witnessed drastic...

Transcatheter valve replacement, especially transcatheter aortic valve implantation (TAVI), took center stage at the Transcatheter Cardiovascular Therapeutics (TCT) 2010 symposium this fall in...

St. Jude Medical Inc. said it plans to acquire AGA Medical Holdings Inc. for about $1.3 billion. The purchase will expand St. Jude’s cardiac device offerings with a portfolio of transcatheter...

October 15, 2010 – An investigational trial of Medtronic’s CoreValve transcatheter aortic valve has been approved by the U.S. Food and Drug Administration (FDA) today. The investigational device...

October 1, 2010 – The most recent clinical data from USpella, a U.S. multicenter, observational registry of patients who received percutaneous cardiac support from the Impella 2.5 device, was...

Transcatheter valve therapies were among the hottest topics at the 2010 Transcatheter Cardiovascular Therapeutics (TCT) symposium and the key presentation was the very positive first release of...

A new class of antiplatelet therapy drug pending U.S. Food and Drug Administration (FDA) clearance may offer greater benefits over clopidogrel (Plavix) the current standard of therapy. The new...

September 14, 2010 – Transcatheter valves, drug-eluting balloons and the latest stent comparison trial data are among the top three trends at Transcatheter Cardiovascular Therapeutics (TCT) 2010...

A major issue in treating chronic total occlusions (CTOs) is the lack of angiographic visualization. The flow of blood and contrast is completely blocked, eliminating the ability to navigate the...